Atomera Incorporated (NASDAQ:ATOM) Shares Sold by Bard Associates Inc.

Bard Associates Inc. decreased its holdings in shares of Atomera Incorporated (NASDAQ:ATOMFree Report) by 2.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 170,775 shares of the technology company’s stock after selling 3,450 shares during the period. Bard Associates Inc. owned approximately 0.59% of Atomera worth $449,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Summit Securities Group LLC acquired a new position in Atomera in the second quarter worth approximately $31,000. Consolidated Planning Corp acquired a new stake in shares of Atomera during the third quarter worth $40,000. Virtu Financial LLC purchased a new stake in shares of Atomera during the first quarter valued at $216,000. GSA Capital Partners LLP lifted its holdings in shares of Atomera by 28.0% during the third quarter. GSA Capital Partners LLP now owns 65,428 shares of the technology company’s stock valued at $172,000 after purchasing an additional 14,327 shares during the last quarter. Finally, Westside Investment Management Inc. boosted its position in shares of Atomera by 13.2% in the 2nd quarter. Westside Investment Management Inc. now owns 95,720 shares of the technology company’s stock valued at $365,000 after purchasing an additional 11,150 shares during the period. Institutional investors and hedge funds own 30.79% of the company’s stock.

Atomera Price Performance

NASDAQ ATOM opened at $5.94 on Friday. The firm’s 50 day moving average price is $3.38 and its two-hundred day moving average price is $3.61. Atomera Incorporated has a twelve month low of $2.31 and a twelve month high of $9.19. The company has a current ratio of 5.25, a quick ratio of 5.25 and a debt-to-equity ratio of 0.05.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum reduced their price objective on shares of Atomera from $13.00 to $7.00 and set a “buy” rating for the company in a research note on Wednesday, July 31st.

Check Out Our Latest Report on Atomera

About Atomera

(Free Report)

Atomera Incorporated engages in the developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors.

Featured Articles

Institutional Ownership by Quarter for Atomera (NASDAQ:ATOM)

Receive News & Ratings for Atomera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atomera and related companies with MarketBeat.com's FREE daily email newsletter.